Xylocaine 1% with Adrenaline 1:200,000

מדינה: ניו זילנד

שפה: אנגלית

מקור: Medsafe (Medicines Safety Authority)

מרכיב פעיל:

Adrenaline acid tartrate 0.0091 mg/mL equivalent to 5 µg/mL adrenaline;  ; Lidocaine hydrochloride 10 mg/mL; Adrenaline acid tartrate 0.0091 mg/mL ([=5mcg/mL adrenaline]); Lidocaine hydrochloride 10 mg/mL; Adrenaline acid tartrate 0.0091 mg/mL ([=5mcg/mL adrenaline]); Lidocaine hydrochloride 10 mg/mL

זמין מ:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (שם בינלאומי):

Adrenaline acid tartrate 0.0091 mg/mL (= 5 µg/mL adrenaline)

טופס פרצבטיות:

Solution for injection

הרכב:

Active: Adrenaline acid tartrate 0.0091 mg/mL equivalent to 5 µg/mL adrenaline   Lidocaine hydrochloride 10 mg/mL Excipient: Hydrochloric acid as 2M solution for pH adjustment (pH 3.3-5.0) Methyl hydroxybenzoate Sodium chloride Sodium hydroxide as 2M solution for pH adjustment (pH 3.3-5.0) Sodium metabisulfite Water for injection Active: Adrenaline acid tartrate 0.0091 mg/mL ([=5mcg/mL adrenaline]) Lidocaine hydrochloride 10 mg/mL Excipient: Carbon dioxide Hydrochloric acid Sodium chloride Sodium metabisulfite Water for injection Active: Adrenaline acid tartrate 0.0091 mg/mL ([=5mcg/mL adrenaline]) Lidocaine hydrochloride 10 mg/mL Excipient: Carbon dioxide Hydrochloric acid Sodium chloride Sodium hydroxide Sodium metabisulfite Water for injection

יחידות באריזה:

Vial, glass, multi-dose, 20mL, 5 dose units

סיווג:

Prescription

סוג מרשם:

Prescription

תוצרת:

Boehringer Ingelheim Pharma GmbH & Co KG

סממני תרפויטית:

XYLOCAINE solutions are indicated for the production of local or regional anaesthesia by the following techniques: · local infiltration · minor or major nerve blocks · epidural block · arthroscopy · intravenous regional anaesthesia

leaflet_short:

Package - Contents - Shelf Life: Vial, glass, multi-dose, 20mL - 5 dose units - 24 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, single dose, 20mL - 5 dose units - 18 months from date of manufacture stored at or below 25°C

תאריך אישור:

1986-06-24

מאפייני מוצר

X
YLOCAINE
Data Sheet
NEW ZEALAND DATA SHEET
1. PRODUCT NAME
Xylocaine 1% Solution for Injection
Xylocaine 2% Solution for Injection
Xylocaine 1% with Adrenaline 1:100,000 Solution for Injection
Xylocaine 1% with Adrenaline 1:200,000 Solution for Injection
Xylocaine 2% with Adrenaline 1:200,000 Solution for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Xylocaine 1%: Each mL of solution for injection contains 10mg of
lidocaine hydrochloride.
Xylocaine 2%: Each mL of solution for injection contains 20mg of
lidocaine hydrochloride.
Xylocaine 1% with Adrenaline 1:100,000: Each mL of solution for
injection contains 10mg of
lidocaine hydrochloride and 10micrograms of adrenaline (epinephrine)
as acid tartrate.
Xylocaine 1% with Adrenaline 1:200,000: Each mL of solution for
injection contains 10mg of
lidocaine hydrochloride and 5micrograms of adrenaline (epinephrine) as
acid tartrate.
Xylocaine 2% with Adrenaline 1:200,000: Each mL of solution for
injection contains 20mg of
lidocaine hydrochloride and 5micrograms of adrenaline (epinephrine) as
acid tartrate.
(Note: Lidocaine is another name for lignocaine. Lidocaine is used in
this document.
Epinephrine is another name for adrenaline. Adrenaline is mostly used
in this document.)
For full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
X
YLOCAINE
solution for injection is a sterile, isotonic aqueous solution. The pH
of the solution
is 5.0-7.0. The ampoules are free from preservatives and are intended
for single use only.
X
YLOCAINE
with adrenaline solution for injection is a sterile, isotonic aqueous
solution. It
contains sodium metabisulphite as an antioxidant. The pH of the
solution is 3.3-5.0.
4. CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
X
YLOCAINE
solutions are indicated for the production of local or regional
anaesthesia by the
following techniques:
•
local infiltration
•
minor or major nerve blocks
•
epidural block
•
arthroscopy
•
intravenous regional anaesthesia
X
YLOCAINE
Data Sheet
Copyright
2
4.2
DOSE AND METHOD OF ADMINISTRA